术前CT影像组学预测食管鳞状细胞癌新辅助化疗免疫治疗反应
这项回顾性研究纳入251例食管鳞状细胞癌患者,利用术前CT提取二维和2.5维深度学习迁移学习特征及影像组学特征,构建支持向量机模型预测新辅助化疗免疫治疗反应;外部测试组中二维和2.5维模型的AUC分别为0.85和0.84,融合模型可有效预测治疗反应。
要点
- 基于ResNet18的二维和2.5维深度学习迁移学习特征联合支持向量机模型表现最佳。
- 外部测试组中二维模型AUC为0.85(95%CI: 0.76, 0.91),2.5维模型AUC为0.84(95%CI: 0.75, 0.91)。
- 支持向量机模型优于其他影像组学和深度学习模型,ResNet18在二维和2.5维模型中预测性能最好。
核心结论
- 整合二维和2.5维深度学习迁移学习特征与影像组学特征的融合模型能有效预测食管鳞状细胞癌患者的新辅助化疗免疫治疗反应。
研究设计与样本
- 回顾性研究,共纳入251例食管鳞状细胞癌患者,来自中山大学肿瘤防治中心(2020年5月至2023年1月)的患者按80%和20%分为训练组和内部验证组,南方医院(2021年1月至2023年3月)患者作为外部测试组;手动提取影像组学特征,从预训练深度学习网络提取二维和2.5维深度迁移学习特征,基于受试者工作特征曲线下面积比较选择最优模型。
诊断标准与关键数值
- 支持向量机模型优于其他影像组学和深度学习模型;ResNet18在二维和2.5维深度学习模型中预测性能最佳;支持向量机联合ResNet18深度迁移学习特征模型在外部测试组中二维深度迁移学习AUC为0.85(95%CI: 0.76, 0.91),2.5维深度迁移学习AUC为0.84(95%CI: 0.75, 0.91)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the performance of a CT-based model combining two-dimensional (2D) and two-and-a-half-dimensional (2.5D) deep learning (DL) with radiomic features in predicting neoadjuvant chemoimmunotherapy response in patients with esophageal squamous cell carcinoma (ESCC). Materials and Methods In this retrospective study, patients with ESCC from Sun Yat-sen Cancer Center between May 2020 and January 2023 were divided into training (80%) and internal validation (20%) groups, while an external testing group was obtained from Nanfang Hospital between January 2021 and March 2023. Radiomic features were extracted manually, while 2D and 2.5D deep transfer learning (DTL) features were derived from pretrained DL networks. The optimal model was selected based on a comparison of the areas under the receiver operating characteristic curves (AUCs). Results In total, 251 patients (mean age, 59.91 years ± 7.63; 209 male and 42 female) were included in the study, with 157 and 94 patients from centers 1 and 2, respectively. The support vector machine (SVM) model outperformed the other radiomic and DL models, while ResNet18 had the best predictive performance among the 2D and 2.5D DL models. The SVM model with ResNet18-based DTL features showed the best performance, achieving AUC values of 0.85 (95% CI: 0.76, 0.91) for 2D DTL and 0.84 (95% CI: 0.75, 0.91) for 2.5D DTL in the external testing group. Conclusion A fusion model integrating 2D and 2.5D DTL and radiomic features effectively predicted the neoadjuvant chemoimmunotherapy response in patients with ESCC. Keywords: Deep Learning, Artificial Intelligence, Prognosis & Prediction, Esophagus, CT Supplemental material is available for this article. © RSNA 2026.
引用
- Chen D, Wang W, Li Q, et al. Preoperative CT-based Radiomics for Predicting Response to Neoadjuvant Chemoimmunotherapy in Esophageal Squamous Cell Carcinoma. Radiol Imaging Cancer. 2026. PMID: 41615298. doi:10.1148/rycan.250128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。